Age and comorbidity are key factors in assessing patient prognosis and informing stopping rules for cancer screening eligibility, but their impact has not been rigorously evaluated in patients with hepatocellular carcinoma (HCC).

中文翻译：

---

高龄但不合并症与肝细胞癌患者生存率较差相关


年龄和合并症是评估患者预后和告知癌症筛查资格停止规则的关键因素，但它们对肝细胞癌 （HCC） 患者的影响尚未得到严格评估。